Cardiopulmonary effects of nitric oxide inhalation and methylene blue injection in hepatopulmonary syndrome

ISSN： 0342-4642

Source： Intensive Care Medicine, Vol.27, Iss.6, 2001-06, pp. : 1103-1104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effects of Caffeic Acid Phenethyl Ester (CAPE) on Hepatopulmonary Syndrome

By Tekin Ahmet

Inflammation, Vol. 34, Iss. 6, 2011-12 ,pp. : 614-619

Springer Publishing Company

Access to resources Recommend Favorite

Effects of an NO-Synthase Inhibitor L-NMMA in the Hepatopulmonary Syndrome

Respiration, Vol. 68, Iss. 2, 2001-03 ,pp. : 226-226

Karger

Access to resources Recommend Favorite

Methylene Blue-Associated Serotonin Syndrome: A `Green' Encephalopathy After Parathyroidectomy

By Rowley Michael

Neurocritical Care, Vol. 11, Iss. 1, 2009-08 ,pp. : 88-93

Humana Press, Inc

Access to resources Recommend Favorite

Methylene blue or patent blue?

ANAESTHESIA, Vol. 59, Iss. 8, 2004-08 ,pp. : 826-826

John Wiley & Sons Inc

Access to resources Recommend Favorite

Vascular nitric oxide: effects of exercise training in animals

By McAllister Richard M. Newcomer Sean C. Laughlin M. H.

Applied Physiology, Nutrition, and Metabolism, Vol. 33, Iss. 1, 2008-01 ,pp. : 173-178

NRC Research Press

Access to resources Recommend Favorite